HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Ingrand Selected Research

Pain (Aches)

3/2015Multicolumn spinal cord stimulation for significant low back pain in failed back surgery syndrome: design of a national, multicentre, randomized, controlled health economics trial (ESTIMET Study).
3/2015"MAST" prospective study: value of minimal access spine technologies technique for multicolumn spinal cord stimulation surgical lead implantation in the context of a French multicentre randomized controlled trial (ESTIMET study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Ingrand Research Topics

Disease

3Neoplasms (Cancer)
07/2017 - 01/2000
3Back Pain (Backache)
03/2015 - 03/2015
2Breast Neoplasms (Breast Cancer)
09/2016 - 04/2001
2Failed Back Surgery Syndrome
03/2015 - 03/2015
2Pain (Aches)
03/2015 - 03/2015
1Prostatic Neoplasms (Prostate Cancer)
10/2021
1Glioma (Gliomas)
07/2020
1Neoplasm Metastasis (Metastasis)
04/2018
1Disease Progression
07/2017
1Macular Degeneration (Age-Related Maculopathy)
09/2016
1Myopia
09/2016
1Atrophy
04/2016
1Choroidal Neovascularization
04/2016
1Epiretinal Membrane (Epiretinal Membranes)
04/2016
1Retinal Detachment (Retinal Detachments)
04/2016
1Retinal Perforations
04/2016
1Measles
02/2016
1Low Back Pain (Lumbago)
03/2015
1Cicatrix (Scar)
03/2015
1Infections
03/2015
1Multiple Sclerosis
04/2011
1Pancreatitis
08/2008
1Obstructive Sleep Apnea
11/2007
1Sleepiness
11/2007
1Headache (Headaches)
06/2002
1Malnutrition (Nutritional Deficiencies)
10/2001
1Cerebral Infarction
01/2001
1Hemorrhage
01/2001
1Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2001
1Lymphoma (Lymphomas)
02/2000
1Obstructive Jaundice (Cholestatic Jaundice)
01/2000

Drug/Important Bio-Agent (IBA)

1Choline (Choline Chloride)IBA
10/2021
1Biomarkers (Surrogate Marker)IBA
07/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
07/2017
1Serum AlbuminIBA
07/2017
1ZeaxanthinsIBA
09/2016
1LuteinIBA
09/2016
1Macular PigmentIBA
09/2016
1Carotenoids (Carotene)IBA
09/2016
1Retinaldehyde (Retinal)IBA
04/2016
1Fluorescein (Funduscein)FDA LinkGeneric
04/2016
1VaccinesIBA
02/2016
1EnzymesIBA
03/2015
1Vitamin DFDA LinkGeneric
04/2011
1Nitroglycerin (Dynamite)FDA LinkGeneric
08/2008
1N 30IBA
06/2002
1Oncogene Proteins (Oncogene Protein)IBA
04/2001
1Epidermal Growth Factor (EGF)IBA
04/2001
1Cathepsin DIBA
04/2001
1Trefoil Factor-1IBA
04/2001
1ErbB Receptors (EGF Receptor)IBA
04/2001
1AnticoagulantsIBA
01/2001
1AnthracyclinesIBA
02/2000
1Methotrexate (Mexate)FDA LinkGeneric
02/2000
1Polyethylene (Polythene)IBA
01/2000
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2000
1NorfloxacinFDA Link
01/2000

Therapy/Procedure

3Radiotherapy
10/2021 - 09/2016
3Drug Therapy (Chemotherapy)
07/2017 - 02/2000
3Spinal Cord Stimulation
03/2015 - 03/2015
2Length of Stay
08/2008 - 10/2001
2Continuous Positive Airway Pressure
11/2007 - 06/2002
1Therapeutics
07/2017
1Gastrostomy
10/2001
1Cranial Irradiation
02/2000
1Stents
01/2000